Literature DB >> 27502036

LH and FSH promote migration and invasion properties of a breast cancer cell line through regulatory actions on the actin cytoskeleton.

Angel Matias Sanchez1, Marina Ines Flamini1, Eleonora Russo2, Elena Casarosa2, Simone Pacini3, Mario Petrini3, Andrea Riccardo Genazzani2, Tommaso Simoncini4.   

Abstract

Reproductive hormones influence breast cancer development and progression. While the actions of sex steroids in this setting are established, tentative evidence suggests that follicle-stimulating hormone (FSH) and luteinizing hormone (LH) may also play a role, yet this remains elusive. We here identify that T-47D breast cancer cells express functional receptors for FSH and LH, and that these hormones regulate breast cancer cell motility and invasion through the control of the actin cytoskeleton and the formation of cortical actin aggregates and focal adhesion complexes. Such actions are mediated by the cytoskeletal controllers Moesin and focal adhesion kinase (FAK). Moesin is recruited rapidly by FSH and LH through a signaling cascade requiring the G protein Gα13 and the Rho-associated kinase, ROCK-2. FSH and LH activate FAK via a Gαi/β and c-Src-dependent signaling cascade. Both cascades involve signaling to phosphatidylinositol-3 kinase and Akt. FSH and LH receptors and the related signaling intermediates are necessary for the actions of gonadotrophins on breast cancer cell cytoskeletal rearrangement, migration and invasion. These findings provide original information on the actions of gonadotrophins on breast cancer cells and may have clinical implications for the use of drugs that modulate gonadotrophins in breast cancer patients.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Breast cancer; FSH; Invasion; LH; Migration

Mesh:

Substances:

Year:  2016        PMID: 27502036     DOI: 10.1016/j.mce.2016.08.009

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  12 in total

1.  Downregulation of microRNA-30c-5p was responsible for cell migration and tumor metastasis via COTL1-mediated microfilament arrangement in breast cancer.

Authors:  Bei Pei; Tongyang Li; Qi Qian; Wenqiang Fan; Xiao He; Yulan Zhu; Lingyun Xu
Journal:  Gland Surg       Date:  2020-06

2.  Discovering biomarkers for hormone-dependent tumors: in silico study on signaling pathways implicated in cell cycle and cytoskeleton regulation.

Authors:  Klaudia Waszczykowska; Karolina Prażanowska; Żaneta Kałuzińska; Damian Kołat; Elżbieta Płuciennik
Journal:  Mol Genet Genomics       Date:  2022-05-09       Impact factor: 3.291

3.  Pre-treatment circulating reproductive hormones levels predict pathological and survival outcomes in breast cancer submitted to neoadjuvant chemotherapy.

Authors:  Ailin Lan; Yudi Jin; Yu Wang; Yihua Wang; Nan Ding; Yuran Dai; Linshan Jiang; Zhenrong Tang; Yang Peng; Shengchun Liu
Journal:  Int J Clin Oncol       Date:  2022-03-03       Impact factor: 3.402

4.  Identification of key transcriptome biomarkers based on a vital gene module associated with pathological changes in Alzheimer's disease.

Authors:  Tong Zhang; Yang Shen; Yiqing Guo; Junyan Yao
Journal:  Aging (Albany NY)       Date:  2021-05-24       Impact factor: 5.682

5.  Follicular Stimulating Hormone Accelerates Atherogenesis by Increasing Endothelial VCAM-1 Expression.

Authors:  Xiaosa Li; Weiyu Chen; Ping Li; Jinzhi Wei; Yang Cheng; Pei Liu; Qing Yan; Xingyan Xu; Yuhong Cui; Zhengtian Gu; Tommaso Simoncini; Xiaodong Fu
Journal:  Theranostics       Date:  2017-10-17       Impact factor: 11.556

6.  A novel potential role of pituitary gonadotropins in the pathogenesis of human colorectal cancer.

Authors:  Wojciech Marlicz; Agata Poniewierska-Baran; Sylwia Rzeszotek; Rafał Bartoszewski; Karolina Skonieczna-Żydecka; Teresa Starzyńska; Mariusz Z Ratajczak
Journal:  PLoS One       Date:  2018-03-01       Impact factor: 3.240

7.  The Gαh-PLCδ1 signaling axis drives metastatic progression in triple-negative breast cancer.

Authors:  Shang-Pen Huang; Pei-Yao Liu; Chih-Jung Kuo; Chi-Long Chen; Wei-Jiunn Lee; Yu-Hui Tsai; Yuan-Feng Lin
Journal:  J Hematol Oncol       Date:  2017-06-02       Impact factor: 17.388

8.  Regulatory Actions of LH and Follicle-Stimulating Hormone on Breast Cancer Cells and Mammary Tumors in Rats.

Authors:  Angel Matias Sanchez; Marina Ines Flamini; Sara Zullino; Eleonora Russo; Andrea Giannini; Paolo Mannella; Antonio Giuseppe Naccarato; Andrea Riccardo Genazzani; Tommaso Simoncini
Journal:  Front Endocrinol (Lausanne)       Date:  2018-05-16       Impact factor: 5.555

9.  Small size fullerenol nanoparticles suppress lung metastasis of breast cancer cell by disrupting actin dynamics.

Authors:  Yanxia Qin; Kui Chen; Weihong Gu; Xinghua Dong; Ruihong Lei; Yanan Chang; Xue Bai; Shibo Xia; Li Zeng; Jiaxin Zhang; Sihan Ma; Juan Li; Shan Li; Gengmei Xing
Journal:  J Nanobiotechnology       Date:  2018-06-23       Impact factor: 10.435

10.  MicroRNA-488 inhibits proliferation and motility of tumor cells via downregulating FSCN1, modulated by Notch3 in breast carcinomas.

Authors:  Yang Wu; Ming-Heng Yuan; Hua-Tao Wu; Wen-Jia Chen; Man-Li Zhang; Qian-Qian Ye; Jing Liu; Guo-Jun Zhang
Journal:  Cell Death Dis       Date:  2020-10-24       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.